Shares of Panacea Biotech slumped around 5 percent intraday on October 13 after the US Food and Drug Administration slapped a Form 483 with nine observations on its biologics manufacturing ...

Panacea Biotech slumps 5% after US FDA issues 9 observations on Baddi facility

A group called the Incubate Coalition, comprising the venture capital firms that bankroll most biotech startups, is pressing US lawmakers to extend by four years the time that pills can be on the ...

Biotech investors push to extend time before pills are subject to price negotiations

While global demand growth in the segment remained generally healthy, the US based biotech segment is showing signs of slowed growth year-on-year as companies adjust to a new funding environment.

Syngene MD and CEO Jonathan Hunt expects US Biotech segments recovery by Q4 after having cut company's FY24 guidance

Tonix Pharmaceuticals Holding Corp. today announced that a study published in the Journal Nature1 by faculty at the Center for Transplantation Sciences, Massachusetts General Hospital (MGH) in collaboration with biotechnology company, eGenesis, utilized ...

Pharm Country

Biotech investment fund reckons sector is poised for growth but Australia not ready to capitalise on growth Per capita, Australia leads biomedical research productivity but invests substantially ...

Global biotech sector set to boom but where are Aussie investors?

On the last day, Concord Biotech had a BSE volume of 22,598 shares, with a closing price of ₹1143.85.

Concord Biotech share price Today Live Updates : Concord Biotech closed today at ₹1174.9, down -1.25% from yesterday's ₹1189.8

REHOVOT, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company ...

Purple Biotech Announces $5 Million Registered Direct Offering

An ambitious plan to harness Serbian scientific expertise and private partners from among the world’s biggest pharma, genetics and healthcare companies has divided expert opinion. Some see it as ...

With Big Private Backers, Serbian Biotech Plan Stirs Hopes and Fears

A Hong Kong company has said leukaemia patients will be able to receive a cancer treatment at a lower cost, after it became the first biotechnology firm in the city to receive a licence to locally ...

Producing cancer therapy cells in Hong Kong will lower treatment cost for leukaemia patients, local biotechnology company says

Gina Calvanese got laid off from Jounce Therapeutics, a struggling Cambridge biotech, in April but landed a higher-paying, six-figure administrative job at a Boston drug maker within days.

‘Like playing the lottery’: Laid-off life sciences workers give a snapshot of a cooling-down sector

Gedea Biotech

Gedea Biotech AB operates as a biotechnology company. The Company develops an antibiotic for the treatment of vaginal fungal infections. Gedea Biotech offers its services in Sweden.

GEDEA BIOTECH

gedeabiotech.com

employees

Since 2015

COMPANY RANKING

GEDEA BIOTECH

EVERGREEN INDEX #2272

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Gedea Biotech

Gedea Biotech WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!

GEDEA BIOTECH

gedeabiotech.com

employees

Since 2015

COMPANY RANKING

GEDEA BIOTECH

EVERGREEN INDEX #2272

RELATED COMPANIESRANK

Representing this company? Click here to claim and customize this page!

Read More Tech Stories Related to #Gedea Biotech

Gedea Biotech WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!